These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1686224)

  • 1. Metabolism in vivo and in vitro of the refrigerant substitute 1,1,1,2-tetrafluoro-2-chloroethane.
    Olson MJ; Johnson JT; O'Gara JF; Surbrook SE
    Drug Metab Dispos; 1991; 19(5):1004-11. PubMed ID: 1686224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 1,2-dichloro-1-fluoroethane and 1-fluoro-1,2,2-trichloroethane: electronic factors govern the regioselectivity of cytochrome P450-dependent oxidation.
    Yin H; Anders MW; Jones JP
    Chem Res Toxicol; 1996; 9(1):50-7. PubMed ID: 8924616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
    Dekant W; Assmann M; Urban G
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation.
    Harris JW; Jones JP; Martin JL; LaRosa AC; Olson MJ; Pohl LR; Anders MW
    Chem Res Toxicol; 1992; 5(5):720-5. PubMed ID: 1446014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative defluorination of 1,1,1,2-tetrafluoroethane by rat liver microsomes.
    Olson MJ; Reidy CA; Johnson JT; Pederson TC
    Drug Metab Dispos; 1990; 18(6):992-8. PubMed ID: 1981550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
    Huwyler J; Aeschlimann D; Christen U; Gut J
    Eur J Biochem; 1992 Jul; 207(1):229-38. PubMed ID: 1628651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
    Urban G; Speerschneider P; Dekant W
    Chem Res Toxicol; 1994; 7(2):170-6. PubMed ID: 8199305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
    Loizou GD; Anders MW
    Drug Metab Dispos; 1993; 21(4):634-9. PubMed ID: 8104122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 1-fluoro-1,1,2-trichloroethane, 1,2-dichloro-1,1-difluoroethane, and 1,1,1-trifluoro-2-chloroethane.
    Yin H; Jones JP; Anders MW
    Chem Res Toxicol; 1995 Mar; 8(2):262-8. PubMed ID: 7766810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
    Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.
    Harris JW; Pohl LR; Martin JL; Anders MW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1407-10. PubMed ID: 1996342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite.
    Baker MT; Bates JN; Leff SV
    Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductive activation of HCFC-123 by methaemalbumin.
    Zanovello A; Ferrara R; Manno M
    Toxicol Lett; 2003 Sep; 144(1):127-36. PubMed ID: 12919730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the hydrochlorofluorocarbon 1,2-dichloro-1,1-difluoroethane.
    Harris JW; Anders MW
    Chem Res Toxicol; 1991; 4(2):180-6. PubMed ID: 1782346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.
    Loizou GD; Anders MW
    Drug Metab Dispos; 1995 Aug; 23(8):875-80. PubMed ID: 7493556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
    Loizou GD; Urban G; Dekant W; Anders MW
    Drug Metab Dispos; 1994; 22(4):511-7. PubMed ID: 7956723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.